FOXBOROUGH, Mass.--(BUSINESS WIRE)--Cyberkinetics Neurotechnology Systems, Inc. (OTCBB: CYKN; “Cyberkinetics”) announced that Ronald G. Emerson, M.D., reported preliminary results from an ongoing study of Cyberkinetics’ NeuroPort™ Neural Monitoring System at the Annual Meeting of the American Clinical Neurophysiology Society in Chicago, Illinois, on Friday, November 3, 2006. The study is currently underway at the Columbia University Medical Center in New York City.
